Pfizer and AFER Ophthalmics initiate awards recognizing the achievements of Dr.

Camras The ARVO Foundation for Eye Study and Pfizer Ophthalmics are very happy to announce a series of awards named in honor of Carl B. Camras, MD. Up to three awards of $10,000 each will be presented annually for an interval of 10 years to early career researchers. The AFER/Pfizer Ophthalmics/Carl Camras Translational Research Awards celebrate the life span and achievements of Dr. Camras, who passed on earlier this year. Dr Camras was a glaucoma expert and research scientist who was most more popular for developing prostaglandin analogues for the treatment of elevated IOP in sufferers with glaucoma. During his distinguished career, he took a personal interest in developing another generation of eyes and vision researchers.The figures result from the NHS Info Center and showed higher entrance rates for older adults than their young counterparts, while males accounted for 63 percent of the admissions.41m last year. The cost was highest in the North-west and the North-east, and lowest in London. Anyone requiring hospital treatment for alcohol – related disease is a cause for concern, and with increasing admissions in all age groups from 16 to 75-plus it’s very clear we cannot afford to rest on our laurels. Now, as never before, we are really happy to crack open a bottle of wine and beverage it in one night. We are taking action to tackle problem drinking already, including plans to avoid supermarkets selling below-cost alcoholic beverages and working to introduce a tougher licensing regime.